These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 1159497)
1. Abnormal spleen scan following MOPP therapy in a patient with Hodgkin's disease: case report. Dickerman JD; Clements JP J Nucl Med; 1975 Jun; 16(6):457-8. PubMed ID: 1159497 [TBL] [Abstract][Full Text] [Related]
2. Pediatric Hodgkin's disease. Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795 [TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy in advanced Hodgkin's disease. Gociu M; Sighetea E; Tănăseanu S; Berceanu S Rev Roum Med Intern; 1973; 10(4):301-5. PubMed ID: 4743748 [No Abstract] [Full Text] [Related]
4. Treatment of Hodgkin's disease. Med Lett Drugs Ther; 1974 Aug; 16(17):69-71. PubMed ID: 4135467 [No Abstract] [Full Text] [Related]
5. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease]. Aghai E; Kende G; Many A; Ramot B Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045 [No Abstract] [Full Text] [Related]
6. [After-care examinations in Hodgkin's disease. Internal medicine and chemotherapy]. Deutsch E; Honetz N Fortschr Geb Rontgenstr Nuklearmed; 1973; 0(0):suppl:120-3. PubMed ID: 4135457 [No Abstract] [Full Text] [Related]
7. [Lipoid nephrosis in a child with advanced Hodgkin's lymphoma]. Gordillo Paniagua G; Velázquez Jones L; Scovino Gudiño R; Arroyo Sierra J; Silva Sosa M; Mota Hernández F Bol Med Hosp Infant Mex; 1977; 34(4):815-21. PubMed ID: 911442 [TBL] [Abstract][Full Text] [Related]
8. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)]. Neumann E Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134 [TBL] [Abstract][Full Text] [Related]
9. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A; J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521 [TBL] [Abstract][Full Text] [Related]
10. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP. Santoro A; Viviani S; Villarreal CJ; Bonfante V; Delfino A; Valagussa P; Bonadonna G Cancer Treat Rep; 1986 Mar; 70(3):343-8. PubMed ID: 2420444 [TBL] [Abstract][Full Text] [Related]
11. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study. Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487 [TBL] [Abstract][Full Text] [Related]
12. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685 [TBL] [Abstract][Full Text] [Related]
13. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771 [TBL] [Abstract][Full Text] [Related]
14. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow]. Fiacchini M; Lauria F; Mazza P; Tura S Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996 [No Abstract] [Full Text] [Related]
15. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease. Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754 [TBL] [Abstract][Full Text] [Related]
16. [Therapy-induced osteosarcoma in Hodgkin's disease]. Donhuijsen K; Bamberg M Schweiz Med Wochenschr; 1981 Jun; 111(24):903-7. PubMed ID: 6944788 [TBL] [Abstract][Full Text] [Related]
17. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results. Bonadonna G; Santoro A; Bonfante V; Valagussa P Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323 [TBL] [Abstract][Full Text] [Related]
18. [The current state of curability of Hodgkin's disease]. Streuli RA; Ultmann JE Schweiz Med Wochenschr; 1981 Sep; 111(36):1301-3. PubMed ID: 7302531 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of Hodgkin's disease]. Brule G Arq Patol; 1974; 46(2-3):273-7. PubMed ID: 4458640 [No Abstract] [Full Text] [Related]
20. Can MOPP be replaced in the treatment of advanced Hodgkin's disease? Canellos GP Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]